Rubric Capital Management LP Reports New 7.74% Stake in Edesa Biotech, Inc. (EDSA)

On May 15, 2026, Rubric Capital Management LP and David Rosen filed a Schedule 13G with the SEC, reporting a new 7.74% stake in Edesa Biotech, Inc. (EDSA). The reporting persons beneficially own 687,500 common shares as of the event date on March 31, 2025. This filing is made jointly by Rubric Capital Management LP, acting as the investment adviser to certain investment funds, and David Rosen, the Managing Member of Rubric Capital Management GP LLC. The reporting persons share voting and dispositive power over the reported shares. Notably, Rubric Long Term Opportunities Offshore Master Fund, LP holds the right to receive dividends or proceeds from more than 5% of the shares. The filing indicates that the securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. The ownership percentage is based on 8,885,719 common shares outstanding as reported in the issuer's proxy statement filed in April 2026.